CDCO has had significant national and international impact on translational drug discovery and development since its establishment in 2003.
- Our researchers have collaborated with more than 60 drug discovery and research groups on more than 120 projects, generating more than $30 million in research funding.
- Our Medicines for Malaria Venture collaboration has been awarded "MMV Project of the Year" no less than five times.
- Our drug discovery collaborations have led to the selection of more than 30 preclinical drug candidates, contributing to programs that have progressed 22 novel drug candidates into clinical development.
- CDCO provides lead optimisation support to drug discovery programs focused on a range of disease indications, including cancer, CNS disorders, cardiovascular disease and infectious diseases.